Biodesix Inc.

BDSX | NASDAQ

Price Alert Chart Builder DCF Calculator

$27.97

-$0.46 (-1.62%)

Sep 22, 2026, 11:55 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.62%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Average

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $227.68M

1D Range

27.86 29.07

52W Range

5.26 31.31

Valuation (TTM)

PE -8.97

PB 25.31

EV/EBITDA -19.13

Valuation (NTM)

Forward PE N/A

Forward PEG 0.24

Price Target $31

Cash Flow

FCF Yield -13.2%

SBC Adj. FCF Yield -15.5%

SBC Impact -16.9%

Margins

Gross Margin 82.5%

Operating Margin -20.0%

FCF Margin -29.8%

Growth (CAGR)

Revenue 3Y | 5Y 35.2% | 6.0%

Dil EPS 3Y | 5Y 50.5% | 54.1%

FCF 3Y | 5Y 37.2% | 9.3%

Returns

ROA -29.1%

ROE -788.2%

ROIC -25.2%

Financial Health

Net Debt

$16.82M

Current Ratio 2.85

Interest Coverage -2.54

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lun...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 334

IPO Date Oct 27, 2020

Website www.biodesix.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$32

Upside

+14.41%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞